Results 131 to 140 of about 66,270 (188)
ESC Heart Failure, EarlyView.Abstract Background Sodium glucose co‐transporter 2 inhibitors (SGLT2i) and mineralocorticoid receptor antagonists (MRA) reduce heart failure (HF) events in patients with heart failure and mildly reduced or preserved ejection fraction (HFmr/pEF). The randomized comparison of SGLT2i/MRA combination versus SGLT2i or MRA alone requires further testing in ...
João Pedro Ferreira +26 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Plasma volume status (PVS) is recognized as a marker of systemic congestion, but its clinical utility in patients with mitral regurgitation (MR) undergoing transcatheter edge‐to‐edge mitral valve repair (M‐TEER) has not been well established. This study aimed to evaluate the prognostic significance of PVS in these patients.
Ai Kagase +30 more
wiley +1 more source
Promotion of Community Based Cultivation of Hibiscus Sabdariffa, Moringa Oleifera, Adansonia Digitata and Aloe Vera for use as Herbal Nutritional Supplements for People living with HIV/AIDS [PDF]
, 2006 Kapingu, M. C. +6 more
core
Prognostic factors in dogs with presumed degenerative mitral valve disease attending primary care veterinary practices in the UK [PDF]
, 2018 Club Kennel +5 more
core +1 more source
Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial
ESC Heart Failure, EarlyView.Abstract Aims Functional mitral regurgitation (FMR) is associated with adverse outcomes in patients with heart failure, and current guideline‐directed medical therapy (GDMT) offers limited efficacy in managing FMR. This study aims to evaluate the therapeutic impact of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in patients with ...
Zhuoshan Huang +18 more
wiley +1 more source
Clinical characteristics and long‐term outcomes in patients with apical hypertrophic cardiomyopathy
ESC Heart Failure, EarlyView.Abstract Aims As a special type of hypertrophic cardiomyopathy (HCM), apical HCM (ApHCM) has different clinical characteristics while its nature history and prognosis are not well recognized. We aimed to describe the characteristics and outcomes of ApHCM and identify predictors of adverse outcomes.
Meng Guo +3 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Atrial functional tricuspid regurgitation (AFTR) is increasingly recognized as a distinct cause of tricuspid regurgitation, yet data on outcomes and their determinants are limited. This study examines the prognostic role of right atrial (RA) remodelling in patients with severe AFTR.
Soongu Kwak +8 more
wiley +1 more source
Prognostic value of left atrial strain in acute and chronic heart failure: A meta‐analysis
ESC Heart Failure, EarlyView.The prognostic evaluation of heart failure (HF) beyond ejection fraction remains challenging. Moreover, reliable prognosticators in chronic HF sometimes lose their value in acute settings or vice versa. Speckle tracking echocardiography offers new sensitive parameters for prognostic stratification in heart failure with reduced and preserved ejection ...
Maria Concetta Pastore +12 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Data support favourable haemodynamic benefits of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) on improving cardiac structural abnormalities and function in patients with heart failure (HF). However, the direct haemodynamic effects of GLP‐1 RAs remain inadequately characterized.
Haoran Jiang +6 more
wiley +1 more source